chronic
obstruct
pulmonari
diseas
copd
asthma
condit
character
fix
variabl
airflow
obstruct
respect
increas
use
inhal
steroid
exacerb
manag
plan
result
decreas
hospit
intens
care
admiss
rate
asthma
true
copd
although
common
overlap
clinic
present
tabl
respons
signific
morbid
mortal
demand
intens
care
servic
etiolog
manag
differ
copd
condit
perman
airflow
obstruct
occur
associ
alveolar
destruct
emphysema
inflamm
airway
wall
chronic
bronchiti
asthma
defin
variabl
airflow
obstruct
revers
complet
partial
spontan
treatment
associ
airway
inflamm
increas
airway
respons
varieti
stimuli
worldwid
estim
billion
peopl
copd
preval
expect
increas
billion
peopl
unit
kingdom
men
women
older
age
year
report
chronic
cough
sputum
men
women
meet
diagnost
criteria
copd
unit
state
copd
estim
occur
adult
commun
result
million
physician
visit
hospit
admiss
per
year
copd
fourth
common
caus
death
worldwid
account
deathsan
ageadjust
rate
risen
comparison
cardiovascular
diseas
stroke
declin
mortal
copd
patient
admit
hospit
exceed
myocardi
infarct
risk
factor
mortal
copd
low
bodi
mass
index
degre
airflow
obstruct
measur
fev
exercis
limit
degre
dyspnea
surviv
also
predict
paco
fig
asthma
estim
occur
children
adult
poorli
control
diseas
lifethreaten
episod
occur
patient
unit
state
asthma
respons
million
emerg
depart
visit
per
year
requir
overnight
admiss
new
zealand
australia
unit
kingdom
greatest
preval
rate
chapter
matthew
naughton
david
v
tuxen
hypercapn
chronic
obstruct
pulmonari
diseas
copd
patient
treat
noninvas
ventil
supplement
oxygen
suffici
overcom
hypoxemia
avoid
hyperoxia
intraven
oral
steroid
copd
limit
day
case
acut
sever
asthma
proof
intraven
administr
shortact
bagonist
advantag
adequ
nebul
administr
sever
asthma
dynam
pulmonari
hyperinfl
due
mechan
ventil
result
hypotens
pnemothorac
sever
asthma
circulatori
collaps
pulseless
electr
activ
ie
electromechan
dissoci
acut
reliev
apnea
test
thereaft
prevent
slow
respiratori
rate
long
expiratori
time
permiss
hypercapnia
follow
acut
sever
exacerb
copd
asthma
precipit
factor
sought
avoid
treat
patientorient
action
plan
institut
avoid
acut
deterior
ninetyf
percent
patient
copd
tobacco
smoke
risk
factor
environment
factor
includ
exposur
secondari
tobacco
smoke
air
pollut
indoor
fume
eg
indoor
cook
solid
biomass
fuel
poor
socioeconom
statu
host
factor
also
import
except
antitrypsin
defici
poorli
understood
although
clear
famili
preval
asthma
sever
gene
implic
singl
gene
defin
could
allow
meaning
genet
plan
number
risk
factor
propos
includ
inadequ
exposur
allergen
due
excess
antibiot
use
excess
clean
dustfre
environ
ie
hygien
hypothesi
excess
exposur
common
allerg
eg
hous
dust
mite
pollen
anim
dander
nonallerg
trigger
eg
cold
air
exercis
atmospher
pollut
exposur
medic
modul
airway
control
eg
aspirin
beta
blocker
increas
preval
asthma
past
year
attribut
increas
environment
exposur
exposur
infect
respiratori
syncyti
viru
parainfluenza
children
chlamydia
adult
implic
risk
factor
stress
socioeconom
statu
also
implic
patient
precipit
identifi
reduct
expiratori
airflow
occur
increas
airway
resist
reduc
lung
elast
recoil
airway
resist
increas
airway
result
mucos
inflamm
basement
membran
thicken
edema
mucos
hypertrophi
secret
bronchospasm
loss
lung
elast
recoil
due
destruct
lung
elastin
reduct
alveolar
surfac
tension
reduc
elast
recoil
decreas
expiratori
airflow
reduc
alveolar
pressur
drive
expiratori
airflow
forc
expir
increas
alveolar
drive
pressur
also
caus
dynam
airway
compress
result
improv
sometim
reduct
expiratori
airflow
import
factor
function
degre
emphysema
individu
patient
hypoxia
vascular
wall
chang
lead
pulmonari
vasoconstrict
pulmonari
hypertens
cor
pulmonal
ventilationtoperfus
heterogen
commonli
smokingrel
copd
result
apic
rather
basal
diseas
fig
wherea
antitrypsin
defici
usual
caus
basal
emphysema
central
respiratori
drive
may
also
poorli
respons
physiolog
trigger
hypercapn
acidosi
contribut
chronic
hypercapnia
may
occur
set
sleep
ie
obstruct
sleep
apnea
obes
drug
sed
antiepilept
alcohol
metabol
disturb
metabol
alkalosi
postmortem
studi
indic
small
airway
narrow
occur
result
bronchial
wall
edema
inflammatori
cell
infiltr
smooth
muscl
hypertrophi
hyperplasia
collagen
deposit
beneath
basement
membran
thicken
intralumin
secret
eosinophil
inflammatori
cell
eosinophil
infiltr
nerv
bundl
releas
major
basic
protein
antagon
inhibitori
muscarin
receptor
present
parasympathet
nerv
end
nocturn
circadian
exacerb
commonli
seen
asthma
due
combin
factor
includ
exposur
cool
dri
air
inhal
excess
allergen
relat
bed
circadian
chang
airway
diamet
cortisol
copd
asthma
pulmonari
hyperinfl
static
dynam
compon
static
compon
increas
function
residu
capac
frc
exist
end
exhal
long
enough
expiratori
airflow
ceas
ie
sec
compon
hyperinfl
primarili
due
airway
closur
occur
throughout
exhal
dynam
hyperinfl
increas
hyperinfl
occur
failur
complet
exhal
begin
inhal
associ
next
breath
extent
dynam
hyperinfl
depend
sever
airflow
obstruct
amount
inspir
ie
tidal
volum
expiratori
time
thu
degre
hyperinfl
may
vari
chang
tidal
volum
andor
respira
tori
rate
occur
respons
chang
co
product
function
exercis
diet
fever
metabol
respons
ill
chang
dead
space
well
chang
airflow
obstruct
occur
exacerb
chest
wall
hyperinfl
put
inspiratori
respiratori
muscl
mechan
disadvantag
increas
work
breath
predispos
patient
develop
respiratori
muscl
fatigu
chronic
use
corticosteroid
electrolyt
disturb
andor
medic
may
also
contribut
problem
copd
minor
reduct
lung
function
due
infect
cardiac
failur
atelectasi
increas
work
breath
increas
airway
resist
lung
stiff
andor
dead
space
may
result
rapid
decompens
ventilatori
failur
acut
hypercapnia
respiratori
acidosi
tidal
volum
fall
result
increas
volum
trap
ga
diminish
respiratori
muscl
strength
exhal
use
accessori
respiratori
muscl
inhal
hyperinfl
may
develop
right
heart
failur
late
cours
contrast
patient
paco
greater
mm
hg
gener
obes
depress
hypox
andor
hypercarb
ventilatori
drive
worsen
excess
oxygen
alcohol
sed
analges
sleeprel
hypoventil
like
develop
right
heart
failur
earli
approxim
patient
acut
exacerb
copd
hypercapn
portion
result
excess
oxygen
administr
acut
exacerb
copd
seem
result
respiratori
infect
cardiac
failur
remain
may
retain
secret
air
pollut
coexist
medic
problem
eg
pulmonari
embolu
gastroesophag
reflux
medic
complianc
side
effect
caus
identifi
box
common
bacteri
isol
streptococcu
pneumonia
hemophilu
influenza
streptococcu
viridan
moraxella
catarrhali
mycobacterium
pneumonia
pseudomona
aeruginosa
may
also
found
virus
isol
exacerb
includ
rhinoviru
influenza
parainfluenza
virus
corona
virus
occasion
adenoviru
respiratori
synciti
viru
isol
exacerb
whether
organ
pathogen
colon
often
unclear
pneumonia
may
account
present
requir
mechan
ventil
left
ventricular
systol
failur
may
result
coexist
ischem
heart
diseas
fluid
overload
tachyarrhythmia
diastol
dysfunct
may
occur
secondari
right
ventricular
dilat
mani
patient
high
level
intrins
posit
endexpiratori
pressur
peep
autopeep
particularli
acut
exacerb
may
decreas
cardiac
output
decreas
venou
return
increas
work
breath
relat
copd
also
contribut
heart
failur
blood
flow
distribut
respiratori
muscl
may
increas
absenc
roentgenograph
evid
pulmonari
edema
left
ventricular
failur
may
difficult
diagnos
uncontrol
oxygen
administr
may
precipit
acut
hypercapnia
patient
acut
copd
exacerb
result
relax
hypox
vasoconstrict
therebi
allow
increas
perfus
region
reduc
alveolar
ventil
although
reduct
hypercarb
drive
previous
thought
account
problem
contribut
abnorm
drive
limit
accur
detail
histori
need
distinguish
asthma
caus
dyspnea
classic
asthmat
patient
wheez
cough
andor
dyspnea
occur
exercis
night
exposur
specif
trigger
asthma
mild
typic
prompt
resolut
follow
inhal
shortact
bagonist
saba
assess
asthma
sever
tabl
triag
crucial
commonli
patient
sever
asthma
histori
previou
hospit
asthma
may
near
fatal
low
socioeconom
statu
femal
gender
obes
nighttim
symptom
fev
less
optim
treatment
continu
symptom
reduc
qualiti
life
use
oral
system
steroid
past
month
use
canist
saba
per
month
elev
residu
volumetotot
lung
capac
rv
tlc
ratio
pulmonari
function
test
peak
expiratori
flow
rate
variabl
ie
variabl
bestworst
best
read
typic
pattern
progress
hour
day
occur
set
histori
recurr
present
form
associ
greater
airway
inflamm
gener
respond
poorli
incomplet
initi
bronchodil
therapi
respond
steroid
bronchodil
hour
day
less
commonli
patient
present
hyperacut
exacerb
interv
onset
symptom
respiratori
failur
less
hour
form
asthma
occur
younger
patient
commonli
male
interven
normal
lung
function
highli
sensit
bronchial
reactiv
trigger
attribut
mark
bronchial
smooth
muscl
contract
form
asthma
respond
saba
treatment
within
minut
hour
physic
examin
includ
assess
speech
abil
speak
sentenc
phrase
word
oxygen
satur
heart
rate
pulsu
paradox
use
accessori
muscl
chest
auscult
consciou
state
respons
immedi
inhal
bronchodil
puls
higher
beatsmin
respiratori
rate
higher
pulsu
paradox
mm
hg
indic
sever
asthma
auscultatori
find
silent
chest
may
indic
extrem
sever
bronchospasm
presenc
pneumothorax
diagnosi
copd
usual
establish
prior
patient
present
respiratori
failur
base
histori
clinic
examin
investig
patient
copd
usual
histori
smoke
packyear
set
exposur
indoor
solid
fuel
heat
cook
famili
histori
antitrypsin
defici
may
caus
contribut
factor
may
histori
chronic
cough
sputum
product
describ
exert
dyspnea
wheez
patient
mild
stabl
diseas
expiratori
wheez
forc
expir
mild
exert
dyspnea
may
find
patient
moder
diseas
modest
sever
exert
dyspnea
associ
clinic
sign
hyperinfl
increas
work
breath
sever
stabl
diseas
mark
accessori
muscl
use
seen
associ
tachypnea
rest
purs
lip
breath
hypoxemia
sign
pulmonari
hypertens
right
ventricular
heav
loud
palpabl
pulmonari
second
sound
elev
wave
jugular
venou
pressur
jvp
cor
pulmonal
elev
jvp
hepatomegali
ankl
swell
sever
unstabl
copd
mark
tachypnea
rest
hypoxemia
tachycardia
case
sign
hypercapnia
dilat
cutan
vein
blur
vision
headach
obtund
mentat
confus
clinic
examin
may
also
identifi
associ
medic
condit
precipit
exacerb
pulmonari
crepit
bronchial
breath
pneumonia
crepit
cardiomegali
relat
heart
failur
mediastin
shift
relat
pneumothorax
sever
copd
best
judg
assess
pulmonari
function
ie
peak
expiratori
flow
rate
pefr
fev
vital
capac
vc
initi
normal
decreas
later
cours
diseas
lesser
degre
fev
fev
vc
ratio
less
fev
predict
without
bronchodil
respons
usual
indic
mild
copd
signific
bronchodil
respons
ie
ml
increas
either
fev
vc
impli
diagnosi
asthma
fev
predict
indic
moder
sever
copd
fev
less
predict
indic
sever
diseas
although
diagnosi
may
base
spirometri
alon
lung
function
test
may
use
character
sever
flow
volum
curv
demonstr
reduc
expiratori
flow
rate
show
characterist
concav
expiratori
flow
pattern
lung
volum
measur
either
helium
dilut
plethysmographi
show
elev
tlc
frc
rv
rv
tlc
ratio
characterist
repres
intrathorac
ga
trap
diffus
capac
measur
alveolar
surfac
area
usual
less
predict
reduc
proport
extent
emphysema
chest
xray
commonli
show
hyperinfl
lung
field
suggest
flatten
diaphragm
best
seen
later
cxr
evid
emphysemat
bulla
andor
pauciti
lung
mark
pulmonari
hypertens
may
suggest
presenc
enlarg
proxim
pulmonari
arteri
attenu
distal
vascular
mark
right
ventricular
enlarg
highresolut
comput
tomographi
ct
scan
show
emphysema
also
confirm
coexist
bronciectasi
scan
less
sensit
standard
chest
ct
scan
slice
detect
pulmonari
lesion
eg
neoplasm
fig
nuclear
ventilationperfus
scan
show
diffus
wellmatch
nonsegment
ventilationperfus
abnorm
degre
sever
match
seen
clinic
arteri
blood
gase
mandatori
assess
degre
hypoxia
hypercapnia
determin
acidbas
statu
serum
bicarbon
level
meqlit
indic
either
renal
compens
chronic
respiratori
acidosi
primari
metabol
alkalosi
eg
diuret
therapi
highdos
steroid
highvolum
gastric
fluid
loss
renal
compens
chronic
hypercapnia
increas
serum
bicarbon
approxim
meqlit
mm
hg
chronic
paco
rise
mm
hg
order
return
ph
low
normal
rang
electrocardiogram
ecg
commonli
normal
may
show
featur
right
atrial
right
ventricular
hypertrophi
strain
includ
p
pulmonal
right
axi
deviat
domin
r
wave
right
bundl
branch
block
st
depress
wave
flatten
invers
chang
may
chronic
may
develop
acut
mark
increas
pulmonari
vascular
resist
ill
ecg
may
also
show
coexist
ischem
heart
diseas
tachycardia
atrial
fibril
occasion
continu
ecg
monitor
requir
identifi
transient
arrhythmia
may
also
precipit
acut
deterior
copd
diagnosi
asthma
usual
appar
histori
examin
test
airflow
obstruct
need
assess
sever
pefr
less
lmin
fev
less
liter
indic
lifethreaten
asthma
situat
repeat
assess
respons
treatment
mild
moder
asthma
arteri
blood
gase
show
respiratori
alkalosi
ventil
gener
increas
sever
asthma
hypoxemia
present
easili
correct
supplement
oxygen
normal
ph
paco
fulmin
diseas
hypercapn
respiratori
acidosi
develop
sever
hypoxemia
respiratori
acidosi
may
compound
lactic
acidosi
intraven
saba
salbutamol
epinephrin
isoprenalin
use
occasion
continu
nebul
salbutamol
produc
lactic
acidosi
chest
xray
rare
show
consolid
obtain
regardless
seek
evid
pneumothorax
chapter
pneumomediastinum
fig
importantli
chest
xray
also
assist
exclud
differenti
diagnos
left
ventricular
failur
possibl
inhal
foreign
bodi
pulmonari
infiltr
found
possibl
allerg
bronchopulmonari
aspergillosi
consid
serum
ige
eosinophil
level
obtain
acut
set
either
elev
diagnosi
extrins
asthma
establish
even
attent
paid
seek
specif
allergen
caus
asthma
alway
consid
eg
inhal
foreign
bodi
aspir
left
ventricular
failur
pulmonari
embolu
pneumothorax
new
asthma
exacerb
alreadi
hospit
patient
like
due
caus
due
asthma
oxygen
given
lowflow
intranas
cannula
lmin
venturi
mask
initi
goal
achiev
arteri
satur
saco
limit
induc
increas
paco
occur
commonli
patient
initi
paco
mm
hg
ph
rise
paco
excess
mm
hg
consid
reduc
fio
sao
versu
increas
level
noninvas
posit
pressur
ventilatori
support
although
high
level
avoid
sao
revers
hypoxia
import
withheld
presenc
hypercapnia
withdrawn
worsen
inadequ
improv
hypoxia
oxygen
suggest
addit
problem
present
eg
pneumonia
pulmonari
edema
pulmonari
embolu
pneumothorax
diagnost
investig
broaden
occur
howev
addit
administ
allevi
hypoxemia
bronchodil
routin
given
exacerb
copd
small
revers
compon
airflow
obstruct
common
bronchodil
may
also
improv
mucociliari
clearanc
secret
anticholinerg
agent
similar
greater
bronchodil
action
bagonist
copd
also
fewer
side
effect
associ
develop
tachyphylaxi
anticholinerg
agent
use
routin
copd
acut
respiratori
failur
mani
believ
agent
first
choic
ipratropium
bromid
mg
ml
given
either
metereddos
inhal
preferenti
nebul
initi
everi
hour
everi
hour
chronic
use
longact
anticholinerg
ie
tiotropium
reduc
incid
exacerb
agent
use
intens
care
set
nebul
bagonist
also
effect
bronchodil
copd
although
may
caus
tachycardia
tremor
mild
reduct
potassium
pao
due
pulmonari
vasodilat
tachyphylaxi
saba
eg
salbutamol
terbutalin
fenoterol
given
metereddos
inhal
nebul
everi
hour
combin
ipratropium
combin
effect
either
agent
alon
con
tinuou
inhal
recommend
shown
increas
side
effect
without
augment
respons
treatment
parenter
administr
also
recommend
stabl
patient
longterm
use
bagonist
may
improv
symptom
dyspnea
particularli
subgroup
copd
object
bronchodil
respons
longact
bagonist
laba
may
also
benefici
effect
symptom
qualiti
life
exercis
capac
aminophyllin
weak
bronchodil
copd
although
studi
suggest
improv
diaphragm
contractil
stimul
respiratori
drive
improv
mucociliari
transport
right
heart
function
antiinflammatori
weak
diuret
studi
shown
small
benefit
frequent
side
effect
given
patient
acut
copd
exacerb
accordingli
literatur
support
includ
medic
treatment
acut
exacerb
shortterm
system
corticosteroid
improv
rate
airflow
limit
patient
acut
copd
exacerb
current
american
thorac
societi
guidelin
cochran
review
recommend
maximum
dose
equival
oral
prednisolon
mgkg
bodi
weight
day
steroid
avoid
deterior
clearli
due
bacteri
pneumonia
without
bronchospasm
longterm
oral
steroid
copd
associ
number
seriou
side
effect
eg
osteoporosi
diabet
peptic
ulcer
myopathi
system
hypertens
fluid
retent
weight
gain
like
impair
qualiti
life
precipit
readmiss
accordingli
longterm
use
avoid
whenev
possibl
small
group
patient
copd
popul
may
improv
fev
follow
week
system
corticosteroid
patient
dose
taper
lowest
possibl
maintain
improv
alternateday
dose
andor
trial
chronic
inhal
steroid
consid
major
patient
longterm
inhal
steroid
improv
lung
function
surviv
although
trial
design
support
pharmaceut
industri
suggest
may
improv
qualiti
life
reduc
hospit
admiss
antibiot
accept
role
treatment
infectioninduc
exacerb
copd
amoxicillin
suitabl
firstlin
agent
h
influenza
pneumonia
catarrahali
chest
xray
suggest
compon
pneumonia
communityacquir
pneumonia
guidelin
follow
treatment
includ
tetracyclin
macrolid
fluoroquinolon
treatment
associ
medic
condit
fluid
overload
diuret
left
heart
failur
digoxin
vasodil
pneumothorax
intercost
drainag
pulmonari
embolu
anticoagul
electrolyt
correct
undertaken
appropri
respiratori
stimul
eg
acetazolamid
medroxyprogesteron
naloxon
doxapram
almitrin
role
attempt
increas
minut
ventil
increas
dynam
hyperinfl
reduc
muscl
effect
therebi
increas
work
breath
fatigu
narcoticor
benzodiazepineinduc
respiratori
depress
best
manag
appropri
antagonistnaloxon
flumazenil
respect
excess
carbohydr
calori
avoid
increas
co
product
may
worsen
respiratori
failur
noninvas
ventil
niv
techniqu
ventilatori
support
provid
via
nasal
facial
total
face
oral
mask
fig
consid
hypercapn
patient
sever
random
control
trial
demonstr
improv
respiratori
physiolog
reduc
mortal
reduc
iatrogen
complic
reduc
need
intub
mechan
ventil
reduc
length
stay
hospit
tabl
fig
studi
shown
good
toler
techniqu
patient
side
effect
improv
oxygen
paco
compar
medic
treat
control
patient
niv
unload
inspiratori
respiratori
muscl
therebi
reduc
work
breath
attend
co
product
immedi
improv
respiratori
acidosi
even
alveolar
ventil
unchang
indic
niv
treat
acut
exacerb
copd
acut
dyspnea
respiratori
rate
higher
beatsmin
paco
higher
mm
hg
ph
less
despit
optim
medic
treatment
although
indic
includ
mild
moder
exacerb
random
studi
use
entri
guidelin
tabl
copd
patient
liber
invas
ventilatori
support
may
also
benefit
niv
although
studi
question
util
use
set
side
effect
niv
includ
discomfort
intoler
skin
necrosi
fig
gastric
distent
barotrauma
aspir
choic
mask
extrem
import
face
mask
gener
prefer
emerg
set
use
complic
air
leak
claustrophobia
discomfort
nasal
skin
damag
larger
face
head
hood
may
better
toler
effect
nasal
mask
suit
longterm
support
usual
recommend
acut
exacerb
invas
ventilatori
support
may
requir
respiratori
failur
progress
despit
previous
discuss
measur
patient
drowsi
uncoop
extremi
decis
ventil
requir
care
consider
patient
may
near
endstag
lung
diseas
whose
qualiti
life
may
justifi
aggress
treatment
obvious
problem
markedli
attenu
primari
care
outpati
specialti
physician
appropri
address
endoflif
issu
patient
prior
acut
exacerb
goal
invas
ventilatori
support
copd
allow
respiratori
muscl
rest
recov
without
caus
atrophi
total
inact
minim
dynam
hyperinfl
varieti
approach
use
pressuresupport
ventil
frequent
employ
milder
exacerb
sinc
autopeep
exist
virtual
everi
patient
acut
exacerb
howev
continu
posit
airway
pressur
cpap
alway
appli
level
cpap
adjust
readjust
empir
observ
work
breath
associ
inspir
observ
esophag
pressur
trace
monitor
adjust
basi
airway
pressur
trace
pressur
support
titrat
achiev
adequ
tidal
volum
ml
adequ
spontan
rate
breathsmin
patient
comfort
without
excess
minut
ventil
mlkgmin
excess
correct
hypercapnia
sever
affect
patient
need
continu
ventil
synchron
intermitt
ventil
dynam
hyperinfl
avoid
use
low
minut
ventil
guid
achiev
use
small
tidal
volum
mlkg
ventil
rate
less
breathsmin
plateau
airway
pressur
pplat
measur
appli
endinspiratori
paus
second
follow
singl
breath
maneuv
shorten
expiratori
time
appli
seri
breath
increas
dynam
hyperinfl
increas
pplat
level
increas
risk
volutrauma
pplat
exce
cm
h
ventil
rate
reduc
higher
minut
ventil
requir
excess
hypercapn
acidosi
degre
dynam
hyperinfl
effect
assess
use
pplat
use
high
inspiratori
flow
rate
recommend
result
shorter
inspiratori
time
henc
longer
expiratori
time
given
ven
figur
seri
arteri
blood
gase
taken
man
sever
smokingrel
copd
fev
ml
hr
demonstr
acut
hyperoxicinduc
hypercapnia
upon
background
chronic
compens
hypercapnia
reduct
inspir
oxygen
concentr
noninvas
ventil
prevent
intub
mechan
ventil
despit
present
sever
hypercapn
acidosi
alter
consciou
state
patient
suitabl
discharg
day
later
tilatori
rate
turn
reduc
dynam
hyperinfl
alveolar
pressur
improv
ga
exchang
dynam
hyperinfl
excess
attend
circulatori
compromis
andor
risk
barotrauma
minut
ventil
decreas
accept
result
hypercapn
acidosi
muscl
relax
avoid
unless
essenti
normal
howev
spontan
ventil
encourag
promot
ongo
respiratori
muscl
activ
minim
wast
flowbi
pressur
support
lowlevel
cpap
may
reduc
work
spontan
breath
promot
better
ventilatori
pattern
care
must
taken
support
increas
dynam
hyperinfl
differ
mechan
lead
circulatori
compromis
risk
barotrauma
flowbi
increas
resist
expiratori
valv
pressur
support
increas
tidal
volum
may
increas
inspiratori
time
cpap
increas
function
residu
capac
patient
invas
ventil
day
fail
trial
extub
noninvas
ventilatori
support
may
benefit
insert
tracheotomi
tube
may
done
via
dilat
selding
surgic
techniqu
gener
former
conveni
done
icu
heal
quickli
upon
remov
advantag
tracheostomi
dead
space
reduc
endotrach
tube
remov
mouth
nose
thu
reduc
local
irrit
sedat
facilit
suction
disadvantag
includ
nosocomi
infect
local
trauma
reduc
capac
cough
effect
loss
natur
humidif
protect
airway
secret
accumul
tracheostomi
even
tracheostomi
cuff
inflat
appropri
reduct
time
ventilatori
support
awak
cooper
patient
allow
period
respiratori
work
maintain
muscl
strength
crucial
eventu
cessat
ventilatori
support
remov
tracheostomi
usual
tracheostomi
safe
remov
suction
occur
less
frequent
everi
hour
patient
capabl
independ
ventil
cough
ie
adequ
muscl
strength
drive
anatom
abnorm
would
preclud
natur
ventil
respons
treatment
within
first
hour
import
predictor
outcom
patient
allow
sit
upright
given
humidifi
oxygen
flow
rate
keep
oxygen
satur
higher
develop
oxygeninduc
hypercapnia
may
indic
either
underli
copd
chronic
hypercapnia
deterior
progress
sever
asthma
saba
salbutamol
albuterol
tertbutalin
isoprenalin
cornerston
acut
asthma
manag
salbutamol
b
select
bronchodil
properti
minim
b
cardiac
toxic
thu
first
choic
bagonist
laba
salmeterol
eformoterol
use
acut
asthma
manag
mode
bronchodil
deliveri
import
consider
multidos
inhal
spacer
devic
greatest
penetr
drug
lung
inexpens
use
patient
mild
moder
sever
cooper
sever
asthma
uncoop
patient
nebul
use
howev
approxim
drug
reach
lung
nebul
requir
liter
per
minut
ga
flow
oper
achiev
electr
air
pump
pressur
oxygen
air
nebul
particl
size
rang
mm
intraven
deliveri
bagonist
advantag
inhal
rout
sever
asthma
standard
approach
initi
nebul
mg
salbutamol
lmin
oxygen
everi
minut
sever
case
everi
hour
mild
moder
asthma
volum
salbutamol
made
ml
salin
shortact
anticholinerg
side
effect
b
agonist
includ
tachycardia
arrhythmia
hypertens
hypotens
tremor
hypokalemia
worsen
ventilationperfus
match
hyperglycemia
lactic
acidosi
mmollit
common
doserel
consequ
intraven
saba
appear
mani
patient
approxim
hour
initi
treatment
stabl
saba
replac
laba
combin
inhal
steroid
cover
laba
use
singl
treatment
asthma
report
event
increas
mortal
particularli
african
american
anticholinerg
use
adjunct
treatment
saba
rather
singl
firstlin
treatment
meter
dose
inhal
prefer
medic
also
administ
via
nebul
usual
dosag
mg
everi
hr
blur
vision
may
occur
due
local
effect
eye
anticholinerg
preservativeinduc
bronchospasm
report
consid
patient
persist
wheez
system
corticosteroid
reduc
hospit
rate
mortal
length
hospit
stay
patient
asthma
mode
action
primarili
decreas
inflammatori
respons
associ
bronchospasm
mucu
secret
onset
action
hour
administr
hydrocortison
mgkg
methylprednisolon
mgkg
given
intraven
prednison
prednisolon
mgkg
given
oral
everi
hour
high
dose
usual
continu
day
clear
clinic
improv
observ
taper
replac
inhal
steroid
side
effect
steroid
includ
hyperglycemia
hypokalemia
hypertens
acut
psychosi
myopathi
gastriti
longer
term
steroid
associ
addit
problem
osteoporosi
cataract
diabet
oral
thrush
secondari
infect
aminophyllin
bronchodilatori
varieti
antiinflammatori
properti
due
abil
inhibit
phosphodiesteras
role
theophyllin
acut
asthma
clear
due
conflict
result
clinic
trial
narrow
chapter
therapeut
window
side
effect
includ
vomit
tachyarrhythmia
headach
restless
convuls
fourthlin
agent
follow
saba
anticholinerg
steroid
usual
dosag
regim
load
dose
mgkg
infus
rate
mgkg
serum
level
need
monitor
sever
altern
treatment
propos
methotrex
intraven
gglobulin
cyclosporin
colchicin
troleandomycoin
lignocain
magnesium
sulfat
either
margin
effect
helium
ga
mixtur
use
sed
ketamin
similar
margin
degre
success
noninvas
ventilatori
support
use
infrequ
sever
year
acut
asthma
recent
year
report
confirm
safeti
efficaci
addit
expiratori
airway
pressur
counter
effect
autopeep
inspiratori
posit
airway
pressur
may
counter
increas
inspiratori
resist
potenti
complic
noninvas
ventil
patientventil
asynchroni
ga
trap
pulmonari
gastric
decreas
cardiac
output
decreas
venou
return
care
monitor
similar
intub
patient
requir
consid
patient
sever
lifethreaten
asthma
tabl
fail
medic
treatment
list
previous
copd
consequ
delay
expiratori
airflow
asthma
inspir
tidal
volum
complet
exhal
function
residu
capac
proport
breath
trap
impair
arriv
new
breath
lung
volum
increas
expiratori
airflow
also
increas
result
increas
small
airway
calib
increas
elast
recoil
pressur
enabl
lung
inflat
equilibrium
point
tidal
volum
abl
exhal
expiratori
time
avail
mild
airflow
obstruct
process
adapt
enabl
requir
minut
ventil
achiev
higher
lung
volum
moder
loss
inspiratori
muscl
power
airflow
obstruct
sever
howev
equilibrium
point
may
encroach
total
lung
capac
hyperinfl
result
airflow
limit
increas
minut
ventil
requir
provid
normal
paco
complaint
need
ventilatori
help
clinic
appear
exhaust
deterior
respiratori
statu
reduc
consciou
state
import
indic
need
intub
specif
paco
first
hour
intub
period
highest
risk
ventilationinduc
dynam
hyperinfl
airflow
obstruct
often
worst
co
product
dead
space
highest
henc
minut
ventil
requir
highest
time
patient
respiratori
distress
clinician
desir
reduc
hypercapn
acidosi
easili
lead
level
ventil
result
excess
dynam
hyperinfl
risk
hypotens
pneumothorac
uncommonli
circulatori
collaps
copd
initi
minut
ventil
restrict
mlkgmin
litersmin
lean
weight
patient
less
tidal
volum
mlkg
ml
lean
weight
patient
less
respiratori
rate
breathsmin
less
deliv
short
inspiratori
time
vi
litersmin
ti
sec
allow
long
expiratori
time
te
sec
minim
dynam
hyperinfl
either
pressur
volum
control
mode
use
achiev
volum
control
mode
establish
result
reliabl
volum
deliveri
prefer
author
peep
use
counter
intrins
peep
possibl
increas
lung
volum
occur
extern
peep
exce
intrins
peep
must
kept
mind
extern
peep
necessari
patient
continu
spontan
ventil
unabl
trigger
ventil
gener
patient
receiv
heavi
sedat
suppress
normal
respons
hypercarbia
bronchospasm
sever
suffici
alveolar
ventil
accomplish
although
patient
may
requir
one
two
bolu
dose
neuromuscular
block
agent
agent
avoid
possibl
concern
profound
longterm
myopathi
thought
occur
frequent
patient
receiv
combin
neuromuscular
block
agent
corticosteroid
initi
ventil
establish
dynam
hyperinfl
assess
measur
pplat
autopeep
observ
respons
central
venou
pressur
blood
pressur
transient
period
reduc
respiratori
rate
ventil
disconnect
pplat
cm
h
circulatori
improv
occur
respiratori
rate
reduc
ventil
reassess
pplat
low
eg
cm
h
hypercapnia
present
respiratori
rate
may
increas
asthma
improv
sedat
may
reduc
spontan
ventil
cpap
mode
pressur
support
occur
cpap
cm
h
introduc
match
autopeep
reduc
work
breath
hypotens
occur
result
sedat
ventilationinduc
dynam
hyperinfl
pneumothorax
hypovolemia
arrhythmia
pplat
commonli
higher
cm
h
equal
import
assess
hypotens
respons
blood
pressur
central
venou
pressur
sec
ventil
disconnect
apnea
test
circulatori
arrest
appar
electromechan
dissoci
recogn
complic
sever
asthma
occur
usual
within
minut
intub
result
sever
cerebr
ischem
injuri
death
recogn
manag
appropri
patient
toler
mechan
ventil
mlkgmin
ventil
howev
small
number
patient
unusu
sever
asthma
develop
lifethreaten
level
dynam
hyperinfl
despit
restrict
minut
ventil
patient
apnea
test
undertaken
ventil
resum
respiratori
rate
breathsmin
common
pitfal
insert
intraven
cannula
chest
belief
circulatori
collaps
due
tension
pneumothorac
procedur
usual
result
complic
seek
reliev
often
difficult
know
pneumothorax
initi
present
apnea
test
preced
intercost
cannula
possibl
incis
blunt
insert
techniqu
use
